• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sophiris Bio Inc

+ Add to Watchlist

SPHS:US

2.1600 USD 0.1800 7.69%

As of 20:10:00 ET on 11/21/2014.

Snapshot for Sophiris Bio Inc (SPHS)

Open: 2.2600 Day's Range: 2.0400 - 2.2600 Volume: 62,618
Previous Close: 2.3400 52wk Range: 2.0400 - 5.1800 1-Yr Rtn: -49.18%

Stock Chart for SPHS

No chart data available.
  • SPHS:US 2.1600
  • 1D
  • 1M
  • 1Y
2.3400
Interactive SPHS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SPHS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -1.9000
Est. EPS (CAD) (12/2014) -1.9160
Est. PEG Ratio -
Market Cap (M USD) 36.38
Shares Outstanding (M) 16.84
30 Day Average Volume 25,827
Price/Book (mrq) 2.0959
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SPHS

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for SPHS

Sophiris Bio Inc. is a urology company with operations based in San Diego developing a late-stage, highly targeted treatment for benign prostatic hyperplasia.

Lars G EkmanChairmanRandall E WoodsPresident/CEO
Peter T SloverChief Financial OfficerAllison HulmeChief Operating Officer
More Company Profile & Key Executives for SPHS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil